[1]

Sansone L, Milani F, Fabrizi R, Belli M, Cristina M, et al. 2023. Nicotine: from discovery to biological effects. International Journal of Molecular Sciences 24(19):14570

doi: 10.3390/ijms241914570
[2]

Murphy SE. 2021. Biochemistry of nicotine metabolism and its relevance to lung cancer. Journal of Biological Chemistry 296:100722

doi: 10.1016/j.jbc.2021.100722
[3]

Goh KW, Ming LC, Al-Worafi YM, Tan CS, Hermansyah A, et al. 2024. Effectiveness of digital tools for smoking cessation in Asian countries: a systematic review. Annals of Medicine 56(1):2271942

doi: 10.1080/07853890.2023.2271942
[4]

Rostami AA, Campbell JL, Pithawalla YB, Pourhashem H, Muhammad-Kah RS, et al. 2022. A comprehensive physiologically based pharmacokinetic (PBPK) model for nicotine in humans from using nicotine-containing products with different routes of exposure. Scientific Reports 12:1091

doi: 10.1038/s41598-022-05108-y
[5]

Przulj D, Smith KM, McRobbie H, Pesola F, Ananina I, et al. 2025. Nicotine delivery from and user reactions to nicotine pouches compared to cigarettes. Psychopharmacology

doi: 10.1007/s00213-025-06961-1
[6]

Yoo J, Jeon J, Baik M, Choi YY, Kim J. 2026. Cardiovascular risk among stroke survivors with combustible and electronic cigarettes: a nationwide study in Korean men. Journal of the American Heart Association 15(2):e044609

doi: 10.1161/jaha.125.044609
[7]

Wójtowicz W, Raszczok K, Wierzbinka M, Jankowska K, Bajdak-Rusinek K, et al. 2025. Wpływ składników papierosów tradycyjnych i elektronicznych na indukcję procesu EMT w raku płuca [The impact of components of traditional and electronic cigarettes on the induction of the EMT process in lung cancer]. Postępy Biochemii 71:361−368

doi: 10.18388/pb.2021_635
[8]

National Health Commission of the People's Republic of China. 2021. 2020 Report on the health hazards of smoking in China. Beijing: People's Medical Publishing House. pp. 7−10 www.nhc.gov.cn/guihuaxxs/c100133/202105/60eefbe50e3b4426b2e83ae8d2f62835.shtml
[9]

Zhao Z, Zhang M, Wu J, Xu X, Ying P, et al. 2020. E-cigarette use among adults in China: findings from repeated cross-sectional surveys in 2015−16 and 2018−19. The Lancet Public Health 5(12):e639−e649

doi: 10.1016/S2468-2667(20)30145-6
[10]

Cornelius ME, Loretan CG, Jamal A, Davis Lynn BC, Mayer M, et al. 2023. Tobacco product use among adults — United States, 2021. Morbidity and Mortality Weekly Report 72(18):475−483

doi: 10.15585/mmwr.mm7218a1
[11]

Balfour DJK, Benowitz NL, Colby SM, Hatsukami DK, Lando HA, et al. 2021. Balancing consideration of the risks and benefits of e-cigarettes. American Journal of Public Health 111(9):1661−1672

doi: 10.2105/AJPH.2021.306416
[12]

Begh R, Conde M, Fanshawe TR, Kneale D, Shahab L, et al. 2025. Electronic cigarettes and subsequent cigarette smoking in young people: a systematic review. Addiction 120(6):1090−1111

doi: 10.1111/add.16773
[13]

Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, et al. 2017. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatrics 171(8):788−797

doi: 10.1001/jamapediatrics.2017.1488
[14]

Alavi R, Dai W, Mazandarani SP, Arechavala RJ, Herman DA, et al. 2024. Adverse cardiovascular effects of nicotine delivered by chronic electronic cigarettes or standard cigarettes captured by cardiovascular intrinsic frequencies. Journal of the American Heart Association 13(18):e035462

doi: 10.1161/jaha.124.035462
[15]

Reynolds BR, Raph SM, Ghoneum AD, Paily R, Waddell SE, et al. 2026. Influence of e-cigarettes and their constituents on cardiac rhythm and arrhythmias. American Journal of Physiology Heart and Circulatory Physiology 330(2):H549−H568

doi: 10.1152/ajpheart.00263.2025
[16]

Alzahrani T. 2026. New-onset atrial fibrillation in a healthy young adult following electronic cigarette use. Journal of Taibah University Medical Sciences 21(1):135−138

doi: 10.1016/j.jtumed.2025.12.010
[17]

WHO. 2024. Clinical treatment guideline for tobacco cessation in adults. World Health Organization, Geneva www.who.int/publications/i/item/9789240096431
[18]

Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T, et al. 2018. Nicotine replacement therapy versus control for smoking cessation. The Cochrane Database of Systematic Reviews 5(5):CD000146

doi: 10.1002/14651858.CD000146.pub5
[19]

Theodoulou A, Chepkin SC, Ye W, Fanshawe TR, Bullen C, et al. 2023. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. The Cochrane Database of Systematic Reviews 2023(6):CD013308

doi: 10.1002/14651858.cd013308.pub2
[20]

Benowitz NL, Hukkanen J, Jacob P III. 2009. Nicotine chemistry, metabolism, kinetics and biomarkers. In Nicotine Psychopharmacology, eds Henningfield JE, London ED, Pogun S. Berlin, Heidelberg: Springer. pp. 29−60 doi: 10.1007/978-3-540-69248-5_2
[21]

McEwan M, Azzopardi D, Gale N, Camacho OM, Hardie G, et al. 2022. A randomised study to investigate the nicotine pharmacokinetics of oral nicotine pouches and a combustible cigarette. European Journal of Drug Metabolism and Pharmacokinetics 47(2):211−221

doi: 10.1007/s13318-021-00742-9
[22]

National Center for Respiratory Medicine, Tobacco Diseases Group of Chinese Thoracic Society, Tobacco Control Working Group of Disease Prevention Committee of Respiratory Physician Branch of Chinese Medical Doctor Association. 2025. Clinical application guidelines for nicotine replacement therapy. Chinese Journal of Health Management 19(5):321−328 (in Chinese)

doi: 10.3760/cma.j.cn115624-20241213-01027
[23]

Belcher V, Haider A, Crowder K, McKenzie M, Woomer H, et al. 2025. An unusual suspect: hyperprolactinemia from nicotine pouches. AACE Endocrinology and Diabetes 12(4):246−248

doi: 10.1016/j.aed.2025.07.013
[24]

Yan K, Xu S, Fang H, Yang H, Su D. 2025. Next-generation immunotherapeutic strategy and clinical advances of vaccines against nicotine addiction. Vaccine 55:127036

doi: 10.1016/j.vaccine.2025.127036
[25]

Scendoni R, Bury E, Ribeiro ILA, Cameriere R, Cingolani M. 2022. Vaccines as a preventive tool for substance use disorder: a systematic review including a meta-analysis on nicotine vaccines' immunogenicity. Human Vaccines & Immunotherapeutics 18(6):2140552

doi: 10.1080/21645515.2022.2140552
[26]

Fraleigh NL, Lewicky JD, Martel AL, Diaz-Mitoma F, Le HT. 2021. Assessing neutralized nicotine distribution using mice vaccinated with the mucosal conjugate nicotine vaccine. Vaccines 9(2):118

doi: 10.3390/vaccines9020118
[27]

Hu Y, Zhao Z, Ehrich M, Zhang C. 2021. Formulation of nanovaccines toward an extended immunity against nicotine. ACS Applied Materials & Interfaces 13(24):27972−27982

doi: 10.1021/acsami.1c07049
[28]

Barbosa Méndez S, Salazar-Juárez A. 2025. NIC6-TT vaccine reduces nicotine-seeking behavior and expression of nicotine-induced locomotor sensitization in rats. Brain Sciences 15(4):364

doi: 10.3390/brainsci15040364
[29]

Hossain MK, Davidson M, Kypreos E, Feehan J, Muir JA, et al. 2022. Immunotherapies for the treatment of drug addiction. Vaccines 10(11):1778

doi: 10.3390/vaccines10111778
[30]

Hicks MJ, Rosenberg JB, De BP, Pagovich OE, Young CN, et al. 2012. AAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessation. Science Translational Medicine 4(140):e3003611

doi: 10.1126/scitranslmed.3003611
[31]

Li D, Qi X, Zhang Z, Mou X, Meng Y, et al. 2026. Synergistic engineering of a GRAS-certified strain: Transforming Bacillus subtilis 168 into a high-performance nicotine scavenger. Journal of Hazardous Materials 513:142503

doi: 10.1016/j.jhazmat.2026.142503
[32]

Hardie G, Gale N, McEwan M, Oscar SM, Ziviani L, et al. 2022. An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy. Scientific Reports 12:14701

doi: 10.1038/s41598-022-19167-8
[33]

Sutkowy P, Hadryś I, Gmys W, Grzempa P, Sobieszczańska A, et al. 2026. Molecular health effects of electronic cigarettes. Biomolecules 16(2):264

doi: 10.3390/biom16020264
[34]

Lerman C, Tyndale R, Patterson F, Wileyto E, Shields P, et al. 2006. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clinical Pharmacology & Therapeutics 79:600−608

doi: 10.1016/j.clpt.2006.02.006
[35]

Bauer SE, Macrea M, Casey A, Dagli E, Eakin MN, et al. 2025. Treatment of nicotine use in adolescents under 18 years of age: an official American thoracic society clinical practice guideline. American Journal of Respiratory and Critical Care Medicine 211(9):1584−1599

doi: 10.1164/rccm.202507-1577st
[36]

Claire R, Chamberlain C, Davey MA, Cooper SE, Berlin I, et al. 2020. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 3(3):CD010078

doi: 10.1002/14651858.cd010078.pub3
[37]

Hajizadeh A, Howes S, Theodoulou A, Klemperer E, Hartmann-Boyce J, et al. 2023. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 5(5):CD000031

doi: 10.1002/14651858.cd000031.pub6
[38]

Hendershot CS, Simmons WK, Jha MK, McKee SA, Yammine L. 2026. Therapeutic potential of glucagon-like peptide-1 receptor agonists for smoking cessation. Biological Psychiatry 00:in press

doi: 10.1016/j.biopsych.2026.04.002
[39]

Spoelstra SK, Schoevers RA, Venema SD, Knegtering H. 2024. Psychedelics as a potential treatment for tobacco use disorder: a systematic review. Discover Mental Health 4(1):37

doi: 10.1007/s44192-024-00095-0